ReviewLife (Basel, Switzerland)2026
Traditional Chinese Medicine Polysaccharides-Based Nano-Drug Delivery Systems: Design Strategies and Combination Platforms in Tumor Therapy.
Review in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Conventional tumor therapies and traditional nanocarrier delivery systems both suffer from multiple limitations. Traditional Chinese medicine polysaccharides (TCMPs), which possess excellent biocompatibility, low toxicity, structurally modifiable characteristics and inherent pharmacological activities, have emerged as promising functional materials for constructing antitumor drug delivery systems and are being gradually applied in tumor combination therapy. This review systematically summarizes the common structural characteristics, biological functions, and structure-activity relationships of representative TCMPs. It further discusses the principal modification strategies used to construct TCMPs-based drug delivery systems and highlights recent progress in their applications in immunotherapy-centered combination therapy. In addition, it outlines their mechanistic basis and therapeutic potential for improving drug delivery efficiency and antitumor efficacy. This review provides theoretical references for the optimal design of such novel systems and guidance for their applications in precision treatment of tumors, while also pointing out some challenges in the translational research of such systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.